subscribeSubscribe
price-trendAsk Us
Acrivon snags $100M to bring Lilly cancer drug into 19th study

Acrivon snags $100M to bring Lilly cancer drug into 19th study
K. LaHucik FIERCEBIOTECH
12 Nov 2021
Share Share
Boosting I-O by targeting a cellular stress pathway

Boosting I-O by targeting a cellular stress pathway
Angus Liu FIERCEBIOTECH
27 Oct 2021
Share Share
Analysts to Lilly: Why did Trulicity and Taltz come up short?

Analysts to Lilly: Why did Trulicity and Taltz come up short?
Eric Sagonowsky FIERCE PHARMA
01 May 2019
Share Share
Lilly dumps phase 2 cancer drugs that survived previous cull

Lilly dumps phase 2 cancer drugs that survived previous cull
Amirah Al Idrus FIERCE BIOTECH
30 Apr 2019
Share Share
Suffering a series of setbacks, Eli Lilly’s oncology executes 2 of its top drugs

Suffering a series of setbacks, Eli Lilly’s oncology executes 2 of its top drugs
John Carroll ENDPTS
30 Apr 2019
Share Share